
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) through any online brokerage.
There are no as such competitors for F/m Emerald Life Sciences Innovation ETF.
There is no analysis for F/m Emerald Life Sciences Innovation ETF to provide a consensus price target.
The stock price for F/m Emerald Life Sciences Innovation ETF (NASDAQ: LFSC) is $46.2892 last updated July 10, 2026 at 4:15 PM EDT.
There are no upcoming dividends for F/m Emerald Life Sciences Innovation ETF.
F/m Emerald Life Sciences Innovation ETF does not have any upcoming earnings scheduled.
There is no upcoming split for F/m Emerald Life Sciences Innovation ETF.
| Sector | Healthcare |
| Category | Short Term Safe |
| Investment Style | Small Cap Growth |
| Fund Inception | Oct 30, 2024 |
| Managers | Nishit Trivedi Joseph W. Garner Kenneth G. Mertz II Stacey L. Sears Terry M. Smith |
| Definition | Fixed income fund portfolio contains a large percentage of securities with low duration and superior credit quality |
| Symbol | Name | Share % |
|---|---|---|
| TVTX | Travere Therapeutics I... | 6.94% |
| LIVN | Livanova Plc | 5.29% |
| COGT | Cogent Biosciences Inc | 7.59% |
| GH | Guardant Health Inc | 3.63% |
| MIRM | Mirum Pharmaceuticals,... | 4.89% |
| UTHR | United Therapeutics Co... | 4.07% |
| SYRE | Spyre Therapeutics Inc | 5.90% |
| KALV | Kalvista Pharmaceutica... | 5.50% |
| NKTR | Nektar Therapeutics Cl... | 3.89% |
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.